864527-72-0

Upstream product

• 172617-84-4 (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)‐2‐ethyl‐3,4,10‐trihydroxy‐13‐{(2R,4R,5S,6S)‐5‐hydroxy‐4‐methoxy‐4,6‐dimethyl-tetrahydropyran‐2‐yloxy}‐11‐{(2S,3R,4S,6R)‐3‐hydroxy‐6‐methyl‐4‐methylamino-tetrahydropyran‐2‐yloxy}‐3,5,6,8,10,12,14‐heptamethyl‐1‐oxa‐6‐azacyclopentadecan‐15‐one 
• 574-98-1 2-(2-bromoethyl)isoindoline-1,3-dione 

Downstream Products

• 957063-09-1 3'-N-demethyl-3'-N-(2-aminoethyl)-9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A 

Relevant academic research and scientific papers

MACROLIDE DERIVATIVES

Compounds represented by formula (I) and the formula (IV) have an inhibitory activity of MMP-9 production, therefore, are useful as a medicine agent with fewer side effects than conventional MMP enzyme activity inhibitors, as a prophylactic and therapeuti

MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

The present invention provides macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.